These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1333544

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Primary resistance to antituberculous drugs in a New Jersey hospital.
    Lin-Greenberg A, Deltieure M.
    N J Med; 1987 Jun; 84(6):427-8. PubMed ID: 3112660
    [No Abstract] [Full Text] [Related]

  • 47. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis].
    Nitti V.
    Arch Tisiol Mal Appar Respir; 1967 Jun; 22(6):519-34. PubMed ID: 4973216
    [No Abstract] [Full Text] [Related]

  • 48. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V, Stefanin E, Chiper P, Stefănescu I, Popescu-Crivina IM, Anghel E, Kosinski E, Daha A, Kosinski M, Floricel N.
    Ftiziologia; 1972 Jun; 21(5):489-94. PubMed ID: 4632131
    [No Abstract] [Full Text] [Related]

  • 49. [Dynamics of the frequency of development of drug resistance in the causative agent of tuberculosis and its effect on the efficacy of treatment of patients with pulmonary tuberculosis].
    Abramovskaia AK, Antipova SI.
    Probl Tuberk; 1988 Jun; (10):24-7. PubMed ID: 3148132
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP, Irtuganova OA, Slogotskaia LV, Smirnova NS, Moroz AM, Borzenko AS, Spasov AA, Smirnova LA, Dzhura PI, Karpov AV, Ivanovskiĭ VB, Pauker MN, Plemiannikova GI.
    Probl Tuberk; 2001 Jun; (8):29-31. PubMed ID: 11767386
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM, Shrentsel' OA.
    Probl Tuberk; 1973 Jun; 51(6):28-31. PubMed ID: 4202910
    [No Abstract] [Full Text] [Related]

  • 54. [Antibiotic resistance of Mycobacterium. Standard test method and its clinical use in Japan].
    Ushiba D.
    Torax; 1966 Mar; 15(1):14-24. PubMed ID: 4957544
    [No Abstract] [Full Text] [Related]

  • 55. Primary resistance to the major anti-tuberculosis drugs in Ethiopia.
    Wolde K, Lemma E, Abdi A.
    Ethiop Med J; 1986 Jan; 24(1):15-8. PubMed ID: 3080312
    [No Abstract] [Full Text] [Related]

  • 56. [A new antitubercular agent: rifampicin].
    Favez G.
    Schweiz Rundsch Med Prax; 1970 Feb 24; 59(8):296-7. PubMed ID: 4996719
    [No Abstract] [Full Text] [Related]

  • 57. [Tuberculosis chemotherapy in cases of resistance].
    Troi K, Marcocci S.
    Prax Klin Pneumol; 1983 Oct 24; 37 Suppl 1():477-8. PubMed ID: 6417641
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Primary drug resistance in adult pulmonary tuberculosis].
    Porven G, Rodriguez EJ, Piccolo R.
    Medicina (B Aires); 1973 Oct 24; 3(6):708-15. PubMed ID: 4217868
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.